Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Bekersky, I' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 46 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bekersky, I; Fitzsimmons, W; Tanase, A; Maher, RM; Hodosh, E; Lawrence, I
      Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitis

      JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
    2. Lee, JW; Petersen, ME; Lin, P; Dressler, D; Bekersky, I
      Quantitation of free and total amphotericin B in human biologic matrices by a liquid chromatography tandem mass spectrometric method

      THERAPEUTIC DRUG MONITORING
    3. Bekersky, I; Fielding, RM; Dressler, DE; Kline, S; Buell, DN; Walsh, TJ
      Pharmacokinetics, excretion, and mass balance of C-14 after administrationof C-14-cholesterol-labeled AmBisome to healthy volunteers

      JOURNAL OF CLINICAL PHARMACOLOGY
    4. Bekersky, I; Dressler, D; Alak, A; Boswell, G; Mekki, QA
      Comparative tacrolimus pharmacokinetics: Normal versus mildly hepatically impaired subjects

      JOURNAL OF CLINICAL PHARMACOLOGY
    5. Bekersky, I; Dressler, D; Mekki, Q
      Effect of time of meal consumption on bioavailability of a single oral 5 mg tacrolimus dose

      JOURNAL OF CLINICAL PHARMACOLOGY
    6. Bekersky, I; Dressler, D; Mekki, QA
      Effect of low- and high-fat meals on tacrolimus absorption following 5 mg single oral doses to healthy human subjects

      JOURNAL OF CLINICAL PHARMACOLOGY
    7. Townsend, RW; Zutshi, A; Bekersky, I
      Biodistribution of 4-[C-14]cholesterol-ambisome following a single intravenous administration to rats

      DRUG METABOLISM AND DISPOSITION
    8. Groll, AH; Mickiene, D; Petraitis, V; Petraitiene, R; Ibrahim, KH; Piscitelli, SC; Bekersky, I; Walsh, TJ
      Compartmental pharmacokinetics and tissue distribution of the antifungal echinocandin lipopeptide micafungin (FK463) in rabbits

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    9. Walsh, TJ; Goodman, JL; Pappas, P; Bekersky, I; Buell, DN; Roden, M; Barrett, J; Anaissie, EJ
      Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: Maximum tolerated dose study

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    10. Mancinelli, LM; Frassetto, L; Floren, LC; Dressler, D; Carrier, S; Bekersky, I; Benet, LZ; Christians, U
      The pharmacokinetics and metabolic disposition of tacrolimus: A comparisonacross ethnic groups

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    11. Bekersky, I; Boswell, GW; Hiles, R; Fielding, RM; Buell, D; Walsh, TJ
      Safety, toxicokinetics and tissue distribution of long-term intravenous liposomal amphotericin B (AmBisome (R)): A 91-day study in rats

      PHARMACEUTICAL RESEARCH
    12. Pirsch, J; Bekersky, I; Vincenti, F; Boswell, G; Woodle, ES; Alak, A; Kruelle, M; Fass, N; Facklam, D; Mekki, Q
      Coadministration of tacrolimus and mycophenolate mofetil in stable kidney transplant patients: Pharmacokinetics and tolerability

      JOURNAL OF CLINICAL PHARMACOLOGY
    13. Chen, HF; Peng, JZ; Luo, HY; Loubeau, M; Wan, XC; Xu, DS; Qi, SJ; Vu, MD; Daloze, P; Fitzsimmons, WE; Bekersky, I; Peets, J; Sehgal, SN; Wu, JP
      Compromised kidney graft rejection response in vervet monkeys after withdrawal of immunosuppressants tacrolimus and sirolimus

      TRANSPLANTATION
    14. Qi, SJ; Xu, DS; Peng, JZ; Vu, MD; Wu, JP; Bekersky, I; Fitzsimmons, WE; Peets, J; Sehgal, S; Daloze, P; Chen, HF
      Effect of tacrolimus (FK506) and sirolimus (rapamycin) mono- and combination therapy in prolongation of renal allograft survival in the monkey

      TRANSPLANTATION
    15. Bekersky, I; Fielding, RM; Buell, D; Lawrence, I
      Lipid-based amphotericin B formulations: from animals to man

      PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY
    16. Bekersky, I; Boswell, GW; Hiles, R; Fielding, RM; Buell, D; Walsh, TJ
      Safety and toxicokinetics of intravenous liposomal amphotericin B (AmBisome (R)) in beagle dogs

      PHARMACEUTICAL RESEARCH
    17. Bekersky, I; Dressler, D; Mekki, QA
      Dose linearity after oral administration of tacrolimus 1-mg capsules at doses of 3, 7, and 10 mg

      CLINICAL THERAPEUTICS
    18. Boswell, GW; Buell, D; Bekersky, I
      AmBisome (liposomal amphotericin B): A comparative review (vol 38, pg 583,1998)

      JOURNAL OF CLINICAL PHARMACOLOGY
    19. Bekersky, I; Buell, D; Boswell, G
      ABELCET (R) treatment - Reply

      JOURNAL OF CLINICAL PHARMACOLOGY
    20. Bekersky, I; Dressler, D; Colburn, W; Mekki, Q
      Bioequivalence of 1 and 5 mg tacrolimus capsules using a replicate study design

      JOURNAL OF CLINICAL PHARMACOLOGY
    21. Hebert, MF; Fisher, RM; Marsh, CL; Dressler, D; Bekersky, I
      Effects of rifampin on tacrolimus pharmacokinetics in healthy volunteers

      JOURNAL OF CLINICAL PHARMACOLOGY
    22. BOSWELL GW; BEKERSKY I; FAY J; WINGARD J; ANTIN J; WEISDORF D; MAHER R; FITZSIMMONS W; NASH R
      TACROLIMUS PHARMACOKINETICS IN BMT PATIENTS

      Bone marrow transplantation
    23. ALAITI S; KANG SW; FIEDLER VC; ELLIS CN; SPURLIN DV; FADER D; ULYANOV G; GADGIL SD; TANASE A; LAWRENCE I; SCOTELLARO P; RAYE K; BEKERSKY I
      TACROLIMUS (FK506) OINTMENT FOR ATOPIC-DERMATITIS - A PHASE-I STUDY IN ADULTS AND CHILDREN

      Journal of the American Academy of Dermatology
    24. BOSWELL GW; BUELL D; BEKERSKY I
      AMBISOME (LIPOSOMAL AMPHOTERICIN-B) - A COMPARATIVE REVIEW

      Journal of clinical pharmacology
    25. WALSH TJ; YELDANDI V; MCEVOY M; GONZALEZ C; CHANOCK S; FREIFELD A; SEIBEL NI; WHITCOMB PO; JAROSINSKI P; BOSWELL G; BEKERSKY I; ALAK A; BUELL D; BARRET J; WILSON W
      SAFETY, TOLERANCE, AND PHARMACOKINETICS OF A SMALL UNILAMELLAR LIPOSOMAL FORMULATION OF AMPHOTERICIN-B (AMBISOME) IN NEUTROPENIC PATIENTS

      Antimicrobial agents and chemotherapy
    26. BOSWELL GW; BEKERSKY I; BUELL D; HILES R; WALSH TJ
      TOXICOLOGICAL PROFILE AND PHARMACOKINETICS OF A UNILAMELLAR LIPOSOMALVESICLE FORMULATION OF AMPHOTERICIN-B IN RATS

      Antimicrobial agents and chemotherapy
    27. CHEN H; QI S; XU D; FITZSIMMONS WE; BEKERSKY I; SEHGAL SN; DALOZE P
      COMBINED EFFECT OF RAPAMYCIN AND FK-506 IN PROLONGATION OF SMALL-BOWEL GRAFT-SURVIVAL IN THE MOUSE

      Transplantation proceedings
    28. CHEN H; QI S; XU D; VU DM; FITZSIMMONS WE; BEKERSKY I; PEETS J; SEHGAL SN; DALOZE P
      FK-506 AND RAPAMYCIN IN COMBINATION ARE NOT ANTAGONISTIC BUT PRODUCE EXTENDED SMALL-BOWEL GRAFT-SURVIVAL IN THE MOUSE

      Transplantation proceedings
    29. FITZSIMMONS WE; BEKERSKY I; DRESSLER D; RAYE K; HODOSH E; MEKKI Q
      DEMOGRAPHIC CONSIDERATIONS IN TACROLIMUS PHARMACOKINETICS

      Transplantation proceedings
    30. BEKERSKY I; DRESSLER D; BOSWELL GW; FERGEN B; TRACEWELL W; MEKKI Q
      BIOEQUIVALENCE OF A NEW STRENGTH TACROLIMUS CAPSULE UNDER DEVELOPMENT

      Transplantation proceedings
    31. WINGARD JR; NASH RA; RATANATHARATHORN V; FAY JW; KLEIN JL; PRZEPIORKA D; MAHER RM; DEVINE SM; BOSWELL G; BEKERSKY I; FITZSIMMONS W
      LACK OF INTERACTION BETWEEN TACROLIMUS (FK506) AND METHOTREXATE IN BONE-MARROW TRANSPLANT RECIPIENTS

      Bone marrow transplantation
    32. LEE JW; SUKOVATY RL; FARMEN RH; DRESSLER DE; ALAK A; BEKERSKY I
      TACROLIMUS (FK506) - VALIDATION OF A SENSITIVE ENZYME-LINKED-IMMUNOSORBENT-ASSAY KIT FOR AND APPLICATION TO A CLINICAL PHARMACOKINETIC STUDY

      Therapeutic drug monitoring
    33. ALAK AM; COOK M; BEKERSKY I
      A HIGHLY SENSITIVE ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR THE DETERMINATION OF TACROLIMUS IN ATOPIC-DERMATITIS PATIENTS

      Therapeutic drug monitoring
    34. GRUESSNER RWG; UCKUN FM; PIRENNE J; NAKHLEH RE; BENEDETTI E; BEKERSKY I; TROPPMANN C; GRUESSNER AC
      RECIPIENT PRECONDITIONING AND DONOR-SPECIFIC BONE-MARROW INFUSION IN A PIG MODEL OF TOTAL BOWEL TRANSPLANTATION

      Transplantation
    35. FLOREN LC; BEKERSKY I; BENET LZ; MEKKI Q; DRESSLER D; LEE JW; ROBERTS JP; HEBERT MF
      TACROLIMUS ORAL BIOAVAILABILITY DOUBLES WITH COADMINISTRATION OF KETOCONAZOLE

      Clinical pharmacology and therapeutics
    36. ALAK A; MOY S; BEKERSKY I
      A HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR THE DETERMINATIONOF AMPHOTERICIN-B SERUM CONCENTRATIONS AFTER THE ADMINISTRATION OF AMBISOME, A LIPOSOMAL AMPHOTERICIN-B FORMULATION

      Therapeutic drug monitoring
    37. ALAITI S; FIEDLER VC; KANG S; ELLIS CN; ULYANOV G; GADGIL SD; BEKERSKY I; TANASE A
      TACROLIMUS (FK506) 0.3-PERCENT OINTMENT IN ATOPIC-DERMATITIS - A PHASE-I PHARMACOKINETIC STUDY

      Journal of investigative dermatology
    38. DRESSLER D; BEKERSKY I; LEE J; TRACEWELL WG; KISICKI J; MEKKI Q
      EFFECT OF MEAL TIME ON TACROLIMUS (T) BIOAVAILABILITY

      Clinical pharmacology and therapeutics
    39. GRUESSNER RWG; FRYER JP; FASOLA C; NAKHLEH RE; GRUESSNER AC; KIM S; DUNN DL; PIRENNE J; BEKERSKY I; BENEDETTI E; TROPPMANN C
      A PROSPECTIVE-STUDY OF FK506 VERSUS CSA AND PIG ATG IN A PORCINE MODEL OF SMALL-BOWEL TRANSPLANTATION

      Transplantation
    40. LIN JR; BEKERSKY I; BROWN NS; MONG S; LEE F; NEWMAN RA; HO DH
      NORMOCALCEMIC EFFECT OF GALLIUM NITRATE IN A HYPERCALCEMIC RAT MODEL

      Cancer research
    41. HILES RA; MONG S; BEKERSKY I; BANKS C; LULHAM G; TELLIER P
      INHALATION TOXICITY OF AEROSOLIZED PENTAMIDINE ISETHIONATE IN RATS AND DOGS

      Fundamental and applied toxicology
    42. BEKERSKY I; PUHL RJ; HANSON G; MONG S
      THE PHARMACOKINETICS OF ZOLINO-2-METHOXYPHENOXY)PROPANE-CENTER-DOT-LACTATE (DMP-CENTER-DOT-LACTATE), A NEW AGENT AGAINST OPPORTUNISTIC INFECTIONS, IN MALE BEAGLE DOGS

      Drug metabolism and disposition
    43. REINHARD MK; BEKERSKY I; SANDERS TW; HARRIS BJ; HOTTENDORF GH
      EFFECTS OF POLYASPARTIC ACID ON PHARMACOKINETICS OF TOBRAMYCIN IN 2 STRAINS OF RAT

      Antimicrobial agents and chemotherapy
    44. HANSON GD; SLATTUM P; TIDWELL RR; BEKERSKY I; MONG S
      DETERMINATION OF 1,3-DI(4-IMIDAZOLINO-2-METHOXYPHENOXY)PROPANE IN RAT, DOG AND HUMAN PLASMA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION

      Journal of chromatography. Biomedical applications
    45. HILES RA; BEKERSKY I; SERABIAN MA; MONG S
      COMPARATIVE TOXICITY IN RATS AND DOGS OF INTRAVENOUS 1,3-DI(4-IMIDAZOLINO-2-METHOXYPHENOXY) PROPANE-CENTER-DOT-LACTATE, A POTENTIAL AGENT FOR THE TREATMENT OF PNEUMOCYSTIS-CARINII PNEUMONIA

      Drug investigation
    46. BEKERSKY I; PUHL RJ; HANSON G; MONG S
      DISPOSITION OF A NEW ANTIINFECTIVE AGENT 1,3-DI(4-IMIDAZOLINO-2-METHOXYPHENOXY)PROPANE IN MALE-RATS

      Drug metabolism and disposition


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/08/20 alle ore 01:07:35